Affiliation: DGHI Faculty

Kevin A. Schulman

Kevin A. Schulman, MD, is a professor of medicine in the Duke University School of Medicine, where he also serves as the director of the Center for Clinical and Genetic Economics and as an associate director of the Duke Clinical Research Institute. He holds a joint appointment as a professor of business administration in Duke University's Fuqua School of Business, where he is the director of the Health Sector Management Program. Dr. Schulman also holds appointments in the Center for Health Services Research in Primary Care in the Durham VA Medical Center, the Duke Center for Clinical Health Policy Research, and the Trent Center for Bioethics, Humanities and History of Medicine.

His research interests include economic evaluation in clinical research; health services research and policy, including access to care and the impact of reimbursement and regulatory policies on clinical practice; and medical decision making, especially in patients with life-threatening conditions.

Dr. Schulman received his MD degree from the New York University School of Medicine and a master's degree in business administration from the Wharton School of the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania. He is a board-certified physician in internal medicine.

Dr. Schulman is an elected member of the American Society for Clinical Investigation, a recipient of the Alice S. Hersh Young Investigator Award from the Association for Health Services Research (now AcademyHealth), and the inaugural recipient of the Dr. Herbert W. Nickens Epidemiology Award from the Association of Black Cardiologists. He has written extensively on his research topics, including peer-reviewed articles in the New England Journal of Medicine, the Journal of the American Medical Association, and Annals of Internal Medicine. He is currently a member of the editorial/advisory boards of five journals, including The American Journal of Medicine, the American Heart Journal, Health Services Research, and Value in Health.

Contact Info:
Office Location:  302 Leland Avenue
Email Address: send me a message

School(s):

Fuqua School of Business
School of Medicine
Department(s):

Health Sector Management
Medicine
Topical Interests:

Economics
Representative Publications   (More Publications)

  1. MA Dinan, TJ Robinson, TM Zagar, CD Scales Jr, LH Curtis, SD Reed, WR Lee, KA Schulman, Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007., International journal of radiation oncology, biology, physics, vol. 82 no. 5 (April, 2012), pp. e781-6, ISSN 1879-355X [doi]  [abs]
  2. UD Patel, KA Schulman, Invited Commentary--Can We Begin With the End in Mind? End-of-Life Care Preferences Before Long-term Dialysis: Comment on "Treatment Intensity at the End-of-Life in Older Adults Receiving Long-term Dialysis"., Archives of internal medicine, vol. 172 no. 8 (April, 2012), pp. 663-4, ISSN 1538-3679 [doi]
  3. AI Baras, AS Baras, KA Schulman, Drug development risk and the cost of capital., Nature reviews. Drug discovery, vol. 11 no. 5 (May, 2012), pp. 347-8, ISSN 1474-1784 [doi]
  4. SD Reed, ZJ Eapen, KA Schulman, End point selection in acute decompensated heart failure clinical trials: economic end points., Heart failure clinics, vol. 7 no. 4 (October, 2011), pp. 529-37, ISSN 1551-7136 [doi]  [abs]
  5. R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, D Khayat, P Boyle, P Autier, IF Tannock, T Fojo, J Siderov, S Williamson, S Camporesi, JG McVie, AD Purushotham, P Naredi, A Eggermont, MF Brennan, ML Steinberg, M De Ridder, SA McCloskey, D Verellen, T Roberts, G Storme, RJ Hicks, PJ Ell, BR Hirsch, DP Carbone, KA Schulman, P Catchpole, D Taylor, J Geissler, NG Brinker, D Meltzer, D Kerr, M Aapro, Delivering affordable cancer care in high-income countries., The lancet oncology, vol. 12 no. 10 (September, 2011), pp. 933-80, ISSN 1474-5488 [doi]  [abs]
  6. JH Sampson, TJ Kaminski, KA Schulman, Our failure to advance new treatments for glioma to market., Journal of neurosurgery, vol. 115 no. 2 (August, 2011), pp. 245-7; discussion 247, ISSN 1933-0693 [doi]
  7. MA Dinan, KL Compton, JK Dhillon, BG Hammill, EM Dewitt, KP Weinfurt, KA Schulman, Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials., Medical care, vol. 49 no. 4 (April, 2011), pp. 415-9, ISSN 1537-1948 [doi]  [abs]
  8. BD Richman, KA Schulman, A cautious path forward on accountable care organizations., JAMA : the journal of the American Medical Association, vol. 305 no. 6 (February, 2011), pp. 602-3, ISSN 1538-3598 [doi]
  9. KA Schulman, SR Tunis, A policy approach to the development of molecular diagnostic tests., Nature biotechnology, vol. 28 no. 11 (November, 2010), pp. 1157-9, ISSN 1546-1696 [doi]  [abs]
  10. A Ahmad, K Schulman, Moving forward with clinical IT on multiple fronts. An interview with Asif Ahmad and Kevin Schulman, M.D., Duke University Health System/Duke UniversityInterview by Mark Hagland., Healthcare informatics : the business magazine for information and communication systems, vol. 27 no. 10 (October, 2010), pp. 45-7, ISSN 1050-9135
  11. WS Yancy Jr, ML Maciejewski, KA Schulman, Animal, vegetable, or ... clinical trial?, Annals of internal medicine, vol. 153 no. 5 (September, 2010), pp. 337-9, ISSN 1539-3704 [doi]
  12. SD Reed, DJ Whellan, Y Li, JY Friedman, SJ Ellis, IL Piña, SJ Settles, L Davidson-Ray, JL Johnson, LS Cooper, CM O'Connor, KA Schulman, HF-ACTION Investigators, Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure., Circulation. Cardiovascular quality and outcomes, vol. 3 no. 4 (July, 2010), pp. 374-81, ISSN 1941-7705 [doi]  [abs]
  13. BT Vaughn, SR DeVrieze, SD Reed, KA Schulman, Can we close the income and wealth gap between specialists and primary care physicians?, Health affairs (Project Hope), vol. 29 no. 5 (May, 2010), pp. 933-40, ISSN 1544-5208 [doi]  [abs]
  14. MA Dinan, LH Curtis, BG Hammill, EF Patz Jr, AP Abernethy, AM Shea, KA Schulman, Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006., JAMA : the journal of the American Medical Association, vol. 303 no. 16 (April, 2010), pp. 1625-31, ISSN 1538-3598 [doi]  [abs]
  15. SW Glickman, W Boulding, M Manary, R Staelin, MT Roe, RJ Wolosin, EM Ohman, ED Peterson, KA Schulman, Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction., Circulation. Cardiovascular quality and outcomes, vol. 3 no. 2 (March, 2010), pp. 188-95, ISSN 1941-7705 [doi]  [abs]
  16. DC Ackerly, SW Glickman, KA Schulman, Economic content in medical journal advertisements for medical devices and prescription drugs., PharmacoEconomics, vol. 28 no. 5 (2010), pp. 429-38, ISSN 1179-2027 [doi]  [abs]
  17. DC Ackerly, AM Valverde, LW Diener, KL Dossary, KA Schulman, Fueling innovation in medical devices (and beyond): venture capital in health care., Health affairs (Project Hope), vol. 28 no. 1 (December, 2008), pp. w68-75, ISSN 1544-5208 [doi]  [abs]
  18. LD DiMartino, BG Hammill, LH Curtis, JS Gottdiener, TA Manolio, NR Powe, KA Schulman, External validity of the cardiovascular health study: a comparison with the Medicare population., Medical care, vol. 47 no. 8 (August, 2009), pp. 916-23, ISSN 1537-1948 [doi]  [abs]
  19. KA Schulman, AV Vidal, DC Ackerly, Personalized medicine and disruptive innovation: implications for technology assessment., Genetics in medicine : official journal of the American College of Medical Genetics, vol. 11 no. 8 (August, 2009), pp. 577-81, ISSN 1530-0366 [doi]
  20. SW Glickman, W Boulding, JM Roos, R Staelin, ED Peterson, KA Schulman, Alternative pay-for-performance scoring methods: implications for quality improvement and patient outcomes., Medical care, vol. 47 no. 10 (October, 2009), pp. 1062-8, ISSN 1537-1948 [doi]  [abs]
  21. SD Reed, Y Li, KJ Anstrom, KA Schulman, Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 27 no. 13 (May, 2009), pp. 2185-91, ISSN 1527-7755 [doi]  [abs]
  22. SD Reed, KA Schulman, Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 12 no. 5 (May, 2009), pp. 637-40, ISSN 1524-4733 [doi]
  23. MA Hall, KA Schulman, Ownership of medical information., JAMA : the journal of the American Medical Association, vol. 301 no. 12 (March, 2009), pp. 1282-4, ISSN 1538-3598 [doi]
  24. SW Glickman, JG McHutchison, ED Peterson, CB Cairns, RA Harrington, RM Califf, KA Schulman, Ethical and scientific implications of the globalization of clinical research., The New England journal of medicine, vol. 360 no. 8 (February, 2009), pp. 816-23, ISSN 1533-4406 [doi]
  25. SD Reed, KJ Anstrom, DM Seils, RM Califf, KA Schulman, Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs., Health affairs (Project Hope), vol. 27 no. 5 (August, 2008), pp. w360-70, ISSN 1544-5208 [doi]  [abs]
  26. AM Shea, LH Curtis, BG Hammill, LD DiMartino, AP Abernethy, KA Schulman, Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy., JAMA : the journal of the American Medical Association, vol. 300 no. 2 (July, 2008), pp. 189-96, ISSN 1538-3598 [doi]  [abs]
  27. T Takahashi, SD Reed, KA Schulman, Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease., Nephrology (Carlton, Vic.), vol. 13 no. 5 (October, 2008), pp. 419-27, ISSN 1440-1797 [doi]  [abs]
  28. AM Shea, BG Hammill, LH Curtis, LA Szczech, KA Schulman, Medical costs of abnormal serum sodium levels., Journal of the American Society of Nephrology : JASN, vol. 19 no. 4 (April, 2008), pp. 764-70, ISSN 1533-3450 [doi]  [abs]
  29. MK Kyle, JS Allsbrook, KA Schulman, Does reimportation reduce price differences for prescription drugs? Lessons from the European Union., Health services research, vol. 43 no. 4 (August, 2008), pp. 1308-24, ISSN 1475-6773 [doi]  [abs]
  30. LH Curtis, DJ Whellan, BG Hammill, AF Hernandez, KJ Anstrom, AM Shea, KA Schulman, Incidence and prevalence of heart failure in elderly persons, 1994-2003., Archives of internal medicine, vol. 168 no. 4 (February, 2008), pp. 418-24, ISSN 0003-9926 [doi]  [abs]
  31. SD Reed, AM Shea, KA Schulman, Economic implications of potential changes to regulatory and reimbursement policies for medical devices., Journal of general internal medicine, vol. 23 Suppl 1 (January, 2008), pp. 50-6, ISSN 1525-1497 [doi]  [abs]
  32. LH Curtis, BG Hammill, MA Bethel, KJ Anstrom, L Liao, JS Gottdiener, KA Schulman, Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study., Current medical research and opinion, vol. 24 no. 1 (January, 2008), pp. 41-50, ISSN 1473-4877 [doi]  [abs]
  33. AK Chatterji, KR Fabrizio, W Mitchell, KA Schulman, Physician-industry cooperation in the medical device industry., Health affairs (Project Hope), vol. 27 no. 6 (February, 2009), pp. 1532-43, ISSN 1544-5208 [doi]  [abs]
  34. BD Richman, K Udayakumar, W Mitchell, KA Schulman, Lessons from India in organizational innovation: a tale of two heart hospitals., Health affairs (Project Hope), vol. 27 no. 5 (March, 2011), pp. 1260-70, ISSN 1544-5208 [doi]  [abs]
  35. AM Shea, LH Curtis, LA Szczech, KA Schulman, Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States., BMC nephrology, vol. 9 (2008), pp. 5, ISSN 1471-2369 [doi]  [abs]
  36. SD Reed, KJ Anstrom, Y Li, KA Schulman, Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia., PharmacoEconomics, vol. 26 no. 5 (2008), pp. 435-46, ISSN 1170-7690  [abs]
  37. SW Glickman, KA Baggett, CG Krubert, ED Peterson, KA Schulman, Promoting quality: the health-care organization from a management perspective., International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua, vol. 19 no. 6 (December, 2007), pp. 341-8, ISSN 1353-4505 [doi]  [abs]
  38. AM Shea, SD Reed, LH Curtis, MJ Alexander, JJ Villani, KA Schulman, Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003., Neurosurgery, vol. 61 no. 6 (December, 2007), pp. 1131-7; discussion 1137-8, ISSN 1524-4040 [doi]  [abs]
  39. JY Friedman, LH Curtis, BG Hammill, JK Dhillon, CH Weaver, S Biswas, AP Abernethy, KA Schulman, The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care?, Cancer, vol. 110 no. 10 (November, 2007), pp. 2304-12, ISSN 0008-543X [doi]  [abs]
  40. LH Curtis, BG Hammill, MA Bethel, KJ Anstrom, JS Gottdiener, KA Schulman, Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study., Diabetes care, vol. 30 no. 10 (October, 2007), pp. 2553-8, ISSN 1935-5548 [doi]  [abs]
  41. LH Curtis, SM Al-Khatib, AM Shea, BG Hammill, AF Hernandez, KA Schulman, Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death., JAMA : the journal of the American Medical Association, vol. 298 no. 13 (October, 2007), pp. 1517-24, ISSN 1538-3598 [doi]  [abs]
  42. SW Glickman, FS Ou, ER DeLong, MT Roe, BL Lytle, J Mulgund, JS Rumsfeld, WB Gibler, EM Ohman, KA Schulman, ED Peterson, Pay for performance, quality of care, and outcomes in acute myocardial infarction., JAMA : the journal of the American Medical Association, vol. 297 no. 21 (June, 2007), pp. 2373-80, ISSN 1538-3598 [doi]  [abs]
  43. RM Califf, RA Harrington, LK Madre, ED Peterson, D Roth, KA Schulman, Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics., Health affairs (Project Hope), vol. 26 no. 1 (May, 2007), pp. 62-74, ISSN 1544-5208 [doi]  [abs]
  44. TT Brown, RM Scheffler, SE Tom, KA Schulman, Does the market value racial and ethnic concordance in physician-patient relationships?, Health services research, vol. 42 no. 2 (April, 2007), pp. 706-26, ISSN 0017-9124 [doi]  [abs]
  45. AT Turer, KW Mahaffey, KL Compton, RM Califf, KA Schulman, Publication or presentation of results from multicenter clinical trials: evidence from an academic medical center., American heart journal, vol. 153 no. 4 (April, 2007), pp. 674-80, ISSN 1097-6744 [doi]  [abs]
  46. SD Reed, RM Califf, KA Schulman, How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation., Health affairs (Project Hope), vol. 25 no. 5 (March, 2007), pp. 1309-17, ISSN 1544-5208 [doi]  [abs]
  47. JS Li, EL Eisenstein, HG Grabowski, ED Reid, B Mangum, KA Schulman, JV Goldsmith, MD Murphy, RM Califf, DK Benjamin Jr, Economic return of clinical trials performed under the pediatric exclusivity program., JAMA : the journal of the American Medical Association, vol. 297 no. 5 (February, 2007), pp. 480-8, ISSN 1538-3598 [doi]  [abs]
  48. SM Kansagra, LH Curtis, KJ Anstrom, KA Schulman, Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001., The American journal of cardiology, vol. 99 no. 3 (February, 2007), pp. 339-43, ISSN 0002-9149 [doi]  [abs]
  49. EL Eisenstein, KJ Anstrom, DF Kong, LK Shaw, RH Tuttle, DB Mark, JM Kramer, RA Harrington, DB Matchar, DE Kandzari, ED Peterson, KA Schulman, RM Califf, Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation., JAMA : the journal of the American Medical Association, vol. 297 no. 2 (January, 2007), pp. 159-68, ISSN 1538-3598 [doi]  [abs]
  50. NJ Meropol, KA Schulman, Cost of cancer care: issues and implications., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 25 no. 2 (January, 2007), pp. 180-6, ISSN 1527-7755 [doi]  [abs]
  51. DJ Whellan, SD Reed, L Liao, SD Gould, CM O'connor, KA Schulman, Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives., The American journal of cardiology, vol. 99 no. 2 (January, 2007), pp. 256-60, ISSN 0002-9149 [doi]  [abs]
  52. Reed SD, Califf RM, Schulman KA. Is there a price to pay for short-term savings in the clinical development of new pharmaceutical products? Drug Inf J. 2007;41:491-499.
  53. JE Williams, KJ Anstrom, JY Friedman, KA Schulman, Racial/ethnic variation in perceptions of medical information sources in Durham County, North Carolina., North Carolina medical journal, vol. 68 no. 6 (March, 2008), pp. 391-8, ISSN 0029-2559  [abs]
  54. FM Torti Jr, SD Reed, KA Schulman, Analytic considerations in economic evaluations of multinational cardiovascular clinical trials., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 9 no. 5 (October, 2006), pp. 281-91, ISSN 1098-3015 [doi]  [abs]
  55. LH Curtis, J Stoddard, JI Radeva, S Hutchison, PE Dans, A Wright, RL Woosley, KA Schulman, Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States., Health services research, vol. 41 no. 3 Pt 1 (June, 2006), pp. 837-55, ISSN 0017-9124 [doi]  [abs]
  56. SW Glickman, EB Rasiel, CD Hamilton, A Kubataev, KA Schulman, Medicine. A portfolio model of drug development for tuberculosis., Science (New York, N.Y.), vol. 311 no. 5765 (March, 2006), pp. 1246-7, ISSN 1095-9203 [doi]
  57. TL Kauf, EJ Velazquez, DR Crosslin, WD Weaver, R Diaz, CB Granger, JJ McMurray, JL Rouleau, PE Aylward, HD White, RM Califf, KA Schulman, The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry., American heart journal, vol. 151 no. 1 (January, 2006), pp. 206-12, ISSN 1097-6744 [doi]  [abs]
  58. KA Schulman, Medicare and cost-effectiveness analysis., The New England journal of medicine, vol. 354 no. 2 (January, 2006), pp. 207-9; author reply 207-9, ISSN 1533-4406 [doi]
  59. SD Reed, JI Radeva, DB Daniel, SH Mody, JB Forlenza, RS McKenzie, KA Schulman, Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial., PharmacoEconomics, vol. 24 no. 5 (2006), pp. 479-94, ISSN 1170-7690  [abs]
  60. DB Ridley, JM Kramer, HH Tilson, HG Grabowski, KA Schulman, Spending on postapproval drug safety., Health affairs (Project Hope), vol. 25 no. 2 (October, 2006), pp. 429-36, ISSN 1544-5208 [doi]  [abs]
  61. GS Ginsburg, RP Konstance, JS Allsbrook, KA Schulman, Implications of pharmacogenomics for drug development and clinical practice., Archives of internal medicine, vol. 165 no. 20 (November, 2005), pp. 2331-6, ISSN 0003-9926 [doi]  [abs]
  62. JY Friedman, KJ Anstrom, KP Weinfurt, M McIntosh, HB Bosworth, EZ Oddone, CM Bright, KA Schulman, Perceived racial/ethnic bias in healthcare in Durham County, North Carolina: a comparison of community and national samples., North Carolina medical journal, vol. 66 no. 4 (November, 2005), pp. 267-75, ISSN 0029-2559  [abs]
  63. SD Reed, JI Radeva, DB Daniel, JM Fastenau, D Williams, KA Schulman, Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia., Current medical research and opinion, vol. 21 no. 10 (October, 2005), pp. 1527-33, ISSN 0300-7995 [doi]  [abs]
  64. J Chang, TL Kauf, S Mahajan, JM Jordan, VB Kraus, TP Vail, SD Reed, MA Omar, KH Kahler, KA Schulman, Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis., Arthritis and rheumatism, vol. 52 no. 8 (August, 2005), pp. 2366-75, ISSN 0004-3591 [doi]  [abs]
  65. SD Reed, JI Radeva, KP Weinfurt, JJ McMurray, MA Pfeffer, EJ Velazquez, JS Allsbrook, LE Masselink, MA Sellers, RM Califf, KA Schulman, VALIANT Investigators, Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)., American heart journal, vol. 150 no. 2 (August, 2005), pp. 323-9, ISSN 1097-6744 [doi]  [abs]
  66. LH Curtis, LE Masselink, T Østbye, S Hutchison, PE Dans, A Wright, RR Krishnan, KA Schulman, Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States., Archives of pediatrics & adolescent medicine, vol. 159 no. 4 (April, 2005), pp. 362-6, ISSN 1072-4710 [doi]  [abs]
  67. KP Weinfurt, Y Li, LD Castel, F Saad, JW Timbie, GA Glendenning, KA Schulman, The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer., Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 16 no. 4 (April, 2005), pp. 579-84, ISSN 0923-7534 [doi]  [abs]
  68. DJ Whellan, V Hasselblad, E Peterson, CM O'Connor, KA Schulman, Metaanalysis and review of heart failure disease management randomized controlled clinical trials., American heart journal, vol. 149 no. 4 (April, 2005), pp. 722-9, ISSN 1097-6744 [doi]  [abs]
  69. SD Reed, KJ Anstrom, A Bakhai, AH Briggs, RM Califf, DJ Cohen, MF Drummond, HA Glick, A Gnanasakthy, MA Hlatky, BJ O'Brien, FM Torti Jr, AA Tsiatis, AR Willan, DB Mark, KA Schulman, Conducting economic evaluations alongside multinational clinical trials: toward a research consensus., American heart journal, vol. 149 no. 3 (March, 2005), pp. 434-43, ISSN 1097-6744 [doi]  [abs]
  70. JI Radeva, SD Reed, Z Kaló, TL Kauf, E Cantu 3rd, N Cretin, KA Schulman, Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation., Clinical transplantation, vol. 19 no. 1 (February, 2005), pp. 122-9, ISSN 0902-0063 [doi]  [abs]
  71. SD Reed, JI Radeva, GA Glendenning, RE Coleman, KA Schulman, Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma., American journal of clinical oncology, vol. 28 no. 1 (February, 2005), pp. 8-16, ISSN 1537-453X  [abs]
  72. EB Rasiel, KP Weinfurt, KA Schulman, Can prospect theory explain risk-seeking behavior by terminally ill patients?, Medical decision making : an international journal of the Society for Medical Decision Making, vol. 25 no. 6 (March, 2006), pp. 609-13, ISSN 0272-989X [doi]  [abs]
  73. SD Reed, KJ Anstrom, JA Ludmer, GA Glendenning, KA Schulman, Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia., Cancer, vol. 101 no. 11 (December, 2004), pp. 2574-83, ISSN 0008-543X [doi]  [abs]
  74. KJ Anstrom, SD Reed, AS Allen, GA Glendenning, KA Schulman, Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia., Cancer, vol. 101 no. 11 (December, 2004), pp. 2584-92, ISSN 0008-543X [doi]  [abs]
  75. JY Friedman, SD Reed, KP Weinfurt, KH Kahler, EB Walter, KA Schulman, Parents' reported preference scores for childhood atopic dermatitis disease states., BMC pediatrics, vol. 4 no. 1 (October, 2004), pp. 21, ISSN 1471-2431 [doi]  [abs]
  76. SM Kansagra, LH Curtis, KA Schulman, Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance., JAMA : the journal of the American Medical Association, vol. 292 no. 14 (October, 2004), pp. 1717-23, ISSN 1538-3598 [doi]  [abs]
  77. LH Curtis, T Østbye, V Sendersky, S Hutchison, PE Dans, A Wright, RL Woosley, KA Schulman, Inappropriate prescribing for elderly Americans in a large outpatient population., Archives of internal medicine, vol. 164 no. 15 (August, 2004), pp. 1621-5, ISSN 0003-9926 [doi]  [abs]
  78. SD Reed, JY Friedman, EJ Velazquez, A Gnanasakthy, RM Califf, KA Schulman, Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)., American heart journal, vol. 148 no. 1 (July, 2004), pp. 122-8, ISSN 1097-6744 [doi]  [abs]
  79. LH Curtis, AW Law, KJ Anstrom, KA Schulman, The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey., Medical care, vol. 42 no. 5 (May, 2004), pp. 439-46, ISSN 0025-7079  [abs]
  80. L Liao, DJ Whellan, K Tabuchi, KA Schulman, Differences in care-seeking behavior for acute chest pain in the United States and Japan., American heart journal, vol. 147 no. 4 (April, 2004), pp. 630-5, ISSN 1097-6744 [doi]  [abs]
  81. SD Reed, JI Radeva, GA Glendenning, F Saad, KA Schulman, Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer., The Journal of urology, vol. 171 no. 4 (April, 2004), pp. 1537-42, ISSN 0022-5347 [doi]  [abs]
  82. KP Weinfurt, LD Castel, Y Li, JW Timbie, GA Glendenning, KA Schulman, Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions., Medical care, vol. 42 no. 2 (February, 2004), pp. 164-75, ISSN 0025-7079 [doi]  [abs]
  83. FA Sloan, JG Trogdon, LH Curtis, KA Schulman, The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarction., Journal of the American Geriatrics Society, vol. 52 no. 2 (February, 2004), pp. 173-81, ISSN 0002-8614  [abs]
  84. DJ Gaskin, KP Weinfurt, LD Castel, V DePuy, Y Li, A Balshem, A Benson, CB Burnett, S Corbett, J Marshall, E Slater, DP Sulmasy, D Van Echo, NJ Meropol, KA Schulman, An exploration of relative health stock in advanced cancer patients., Medical decision making : an international journal of the Society for Medical Decision Making, vol. 24 no. 6 (March, 2005), pp. 614-24, ISSN 0272-989X [doi]  [abs]
  85. DB Ridley, KA Schulman, Differential pricing of pharmaceuticals in the internet age., The Journal of ambulatory care management, vol. 27 no. 3 (August, 2004), pp. 210-4, ISSN 0148-9917  [abs]
  86. DM Seils, KA Schulman, Perceptions of racial and ethnic differences in access to healthcare., North Carolina medical journal, vol. 65 no. 6 (March, 2005), pp. 350-2, ISSN 0029-2559
  87. FM Torti Jr, LP Gwyther, SD Reed, JY Friedman, KA Schulman, A multinational review of recent trends and reports in dementia caregiver burden., Alzheimer disease and associated disorders, vol. 18 no. 2 (September, 2004), pp. 99-109, ISSN 0893-0341  [abs]
  88. FA Sloan, JG Trogdon, LH Curtis, KA Schulman, Does the ownership of the admitting hospital make a difference? Outcomes and process of care of Medicare beneficiaries admitted with acute myocardial infarction., Medical care, vol. 41 no. 10 (October, 2003), pp. 1193-205, ISSN 0025-7079 [doi]  [abs]
  89. NJ Meropol, KP Weinfurt, CB Burnett, A Balshem, AB Benson 3rd, L Castel, S Corbett, M Diefenbach, D Gaskin, Y Li, S Manne, J Marshall, JH Rowland, E Slater, DP Sulmasy, D Van Echo, S Washington, KA Schulman, Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 21 no. 13 (July, 2003), pp. 2589-96, ISSN 0732-183X [doi]  [abs]
  90. D Polsky, JS Mandelblatt, JC Weeks, L Venditti, YT Hwang, HA Glick, J Hadley, KA Schulman, Economic evaluation of breast cancer treatment: considering the value of patient choice., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 21 no. 6 (March, 2003), pp. 1139-46, ISSN 0732-183X  [abs]
  91. AW Law, SD Reed, JS Sundy, KA Schulman, Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey., The Journal of allergy and clinical immunology, vol. 111 no. 2 (February, 2003), pp. 296-300, ISSN 0091-6749  [abs]
  92. LH Curtis, T Østbye, V Sendersky, S Hutchison, NM Allen LaPointe, SM Al-Khatib, S Usdin Yasuda, PE Dans, A Wright, RM Califf, RL Woosley, KA Schulman, Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients., The American journal of medicine, vol. 114 no. 2 (February, 2003), pp. 135-41, ISSN 0002-9343  [abs]
  93. KA Schulman, DM Seils, Outcomes research in oncology: improving patients' experiences with cancer treatment., Clinical therapeutics, vol. 25 no. 2 (February, 2003), pp. 665-70, ISSN 0149-2918  [abs]
  94. KA Schulman, EA Stadtmauer, SD Reed, HA Glick, LJ Goldstein, JM Pines, JA Jackman, S Suzuki, MJ Styler, PA Crilley, TR Klumpp, KF Mangan, JH Glick, Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer., Bone marrow transplantation, vol. 31 no. 3 (February, 2003), pp. 205-10, ISSN 0268-3369 [doi]  [abs]
  95. LD Castel, JW Timbie, V Sendersky, LH Curtis, KA Feather, KA Schulman, Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care., BMC health services research, vol. 3 no. 1 (January, 2003), pp. 1, ISSN 1472-6963  [abs]
  96. SD Reed, JY Friedman, A Gnanasakthy, KA Schulman, Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial., International journal of technology assessment in health care, vol. 19 no. 2 (2003), pp. 396-406, ISSN 0266-4623  [abs]
  97. BR Shah, SD Reed, J Francis, DB Ridley, KA Schulman, The cost of inefficiency in US hospitals, 1985-1997., Journal of health care finance, vol. 30 no. 1 (2003), pp. 1-9, ISSN 1078-6767  [abs]
  98. D Polsky, NL Keating, JC Weeks, KA Schulman, Patient choice of breast cancer treatment: impact on health state preferences., Medical care, vol. 40 no. 11 (November, 2002), pp. 1068-79, ISSN 0025-7079 [doi]  [abs]
  99. JE Onken, JY Friedman, S Subramanian, KP Weinfurt, SD Reed, JH Malenbaum, T Schmidt, KA Schulman, Treatment patterns and costs associated with sessile colorectal polyps., The American journal of gastroenterology, vol. 97 no. 11 (November, 2002), pp. 2896-901, ISSN 0002-9270 [doi]  [abs]
  100. KA Schulman, DM Seils, JW Timbie, J Sugarman, LA Dame, KP Weinfurt, DB Mark, RM Califf, A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors., The New England journal of medicine, vol. 347 no. 17 (October, 2002), pp. 1335-41, ISSN 1533-4406 [doi]  [abs]
  101. KP Weinfurt, SM Trucco, RJ Willke, KA Schulman, Measuring agreement between patient and proxy responses to multidimensional health-related quality-of-life measures in clinical trials. An application of psychometric profile analysis., Journal of clinical epidemiology, vol. 55 no. 6 (June, 2002), pp. 608-18, ISSN 0895-4356  [abs]
  102. CH Weaver, CD Buckner, LH Curtis, K Bajwa, KP Weinfurt, BJ Wilson-Relyea, KA Schulman, Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy., Bone marrow transplantation, vol. 29 no. 2 (January, 2002), pp. 159-64, ISSN 0268-3369 [doi]  [abs]
  103. L DesHarnais Castel, K Bajwa, JP Markle, JW Timbie, C Zacker, KA Schulman, A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease., Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 9 no. 7 (October, 2001), pp. 545-51, ISSN 0941-4355  [abs]
  104. D Polsky, KP Weinfurt, B Kaplan, J Kim, J Fastenau, KA Schulman, An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation., Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 16 no. 5 (May, 2001), pp. 1028-33, ISSN 0931-0509  [abs]
  105. AK Berger, JA Breall, BJ Gersh, AE Johnson, WJ Oetgen, TA Marciniak, KA Schulman, Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)., The American journal of cardiology, vol. 87 no. 3 (February, 2001), pp. 272-7, ISSN 0002-9149  [abs]
  106. KA Schulman, KR Yabroff, J Kong, KF Gold, LE Rubenstein, AJ Epstein, H Glick, A claims data approach to defining an episode of care., Pharmacoepidemiology and drug safety, vol. 10 no. 5 (August, 2002), pp. 417-27, ISSN 1053-8569 [doi]  [abs]
  107. DM Seils, JY Friedman, KA Schulman, Sex differences in the referral process for invasive cardiac procedures., Journal of the American Medical Women's Association (1972), vol. 56 no. 4 (2001), pp. 151-4, 160, ISSN 0098-8421  [abs]
  108. KR Meehan, EM Areman, SG Ericson, C Matias, R Seifeldin, K Schulman, Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs., Journal of hematotherapy & stem cell research, vol. 9 no. 5 (October, 2000), pp. 767-71, ISSN 1525-8165 [doi]  [abs]
  109. SE Sheifer, SS Rathore, BJ Gersh, KP Weinfurt, WJ Oetgen, JA Breall, KA Schulman, Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics., Circulation, vol. 102 no. 14 (October, 2000), pp. 1651-6, ISSN 1524-4539  [abs]
  110. KR Meehan, CO Matias, SS Rathore, SG Sandler, J Kallich, J LaBrecque, H Erder, KA Schulman, Platelet transfusions: utilization and associated costs in a tertiary care hospital., American journal of hematology, vol. 64 no. 4 (August, 2000), pp. 251-6, ISSN 0361-8609  [abs]
  111. SS Rathore, AK Berger, KP Weinfurt, M Feinleib, WJ Oetgen, BJ Gersh, KA Schulman, Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly., Circulation, vol. 102 no. 6 (August, 2000), pp. 642-8, ISSN 1524-4539  [abs]
  112. SS Rathore, LA Lenert, KP Weinfurt, A Tinoco, CK Taleghani, W Harless, KA Schulman, The effects of patient sex and race on medical students' ratings of quality of life., The American journal of medicine, vol. 108 no. 7 (May, 2000), pp. 561-6, ISSN 0002-9343  [abs]
  113. SE Sheifer, JJ Escarce, KA Schulman, Race and sex differences in the management of coronary artery disease., American heart journal, vol. 139 no. 5 (May, 2000), pp. 848-57, ISSN 0002-8703  [abs]
  114. KP Weinfurt, RJ Willke, HA Glick, WW Freimuth, KA Schulman, Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients., Medical care, vol. 38 no. 4 (April, 2000), pp. 404-10, ISSN 0025-7079  [abs]
  115. LC Einbinder, KA Schulman, The effect of race on the referral process for invasive cardiac procedures., Medical care research and review : MCRR, vol. 57 Suppl 1 (2000), pp. 162-80, ISSN 1077-5587  [abs]
  116. Sulmasy DP, Freeman VG, Schulman KA. The Factuality of Health Records. Arch Intern Med. 2000 Jul 24;160(14):2224-2225.
  117. WD Bentham, L Cai, KA Schulman, Characteristics of hospitalizations of HIV-infected patients: an analysis of data from the 1994 healthcare cost and utilization project., Journal of acquired immune deficiency syndromes (1999), vol. 22 no. 5 (December, 1999), pp. 503-8, ISSN 1525-4135  [abs]
  118. KA Schulman, SS Mehta, BJ Gersh, EC Schneider, CS Wilcox, Study of Hypertensive Prescribing Practices (SHyPP): A National Survey of Primary Care Physicians., Journal of clinical hypertension (Greenwich, Conn.), vol. 1 no. 2 (October, 1999), pp. 106-114, ISSN 1751-7176  [abs]
  119. KP Weinfurt, SS Rathore, KA Schulman, ACI-TIPI clinical trial. Acute cardiac ischemia time-insensitive predictive instrument., Annals of internal medicine, vol. 131 no. 6 (September, 1999), pp. 476-7, ISSN 0003-4819
  120. SE Sheifer, KA Schulman, Racial differences in the use of invasive cardiac procedures: A continuous quality improvement approach., American heart journal, vol. 138 no. 3 Pt 1 (September, 1999), pp. 396-9, ISSN 0002-8703
  121. SS Mehta, S Suzuki, HA Glick, KA Schulman, Determining an episode of care using claims data. Diabetic foot ulcer., Diabetes care, vol. 22 no. 7 (July, 1999), pp. 1110-5, ISSN 0149-5992  [abs]
  122. KA Schulman, DR Abernethy, SS Rathore, RL Woosley, Regulating manufacturer-affiliated communication in the information age., Clinical pharmacology and therapeutics, vol. 65 no. 6 (June, 1999), pp. 593-7, ISSN 0009-9236 [doi]
  123. KA Schulman, KR Yabroff, J Kong, KF Gold, LE Rubenstein, AJ Epstein, H Glick, A claims data approach to defining an episode of care., Health services research, vol. 34 no. 2 (June, 1999), pp. 603-21, ISSN 0017-9124  [abs]
  124. WL Boyko Jr, HA Glick, KA Schulman, Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. ACE inhibitors in the management of congestive heart failure: comparative economic data., American heart journal, vol. 137 no. 5 (May, 1999), pp. S115-9, ISSN 0002-8703
  125. SS Mehta, CS Wilcox, KA Schulman, Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP)., American journal of hypertension, vol. 12 no. 4 Pt 1 (April, 1999), pp. 333-40, ISSN 0895-7061  [abs]
  126. KA Schulman, R Birch, B Zhen, N Pania, CH Weaver, Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 17 no. 4 (April, 1999), pp. 1227, ISSN 0732-183X  [abs]
  127. KE De Jonge, DP Sulmasy, KG Gold, A Epstein, MG Harper, JM Eisenberg, KA Schulman, The timing of do-not-resuscitate orders and hospital costs., Journal of general internal medicine, vol. 14 no. 3 (March, 1999), pp. 190-2, ISSN 0884-8734  [abs]
  128. KA Schulman, A Ohishi, J Park, HA Glick, JM Eisenberg, Clinical economics in clinical trials: the measurement of cost and outcomes in the assessment of clinical services through clinical trials., The Keio journal of medicine, vol. 48 no. 1 (March, 1999), pp. 1-11, ISSN 0022-9717  [abs]
  129. KA Schulman, JA Berlin, W Harless, JF Kerner, S Sistrunk, BJ Gersh, R Dubé, CK Taleghani, JE Burke, S Williams, JM Eisenberg, JJ Escarce, The effect of race and sex on physicians' recommendations for cardiac catheterization., The New England journal of medicine, vol. 340 no. 8 (February, 1999), pp. 618-26, ISSN 0028-4793 [doi]  [abs]
  130. HA Glick, D Polsky, RJ Willke, KA Schulman, A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index., Medical decision making : an international journal of the Society for Medical Decision Making, vol. 19 no. 3 (September, 1999), pp. 265-75, ISSN 0272-989X  [abs]
  131. KP Weinfurt, R Willke, HA Glick, KA Schulman, Towards a composite scoring solution for the Neurobehavioral Functioning Inventory., Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, vol. 8 no. 1-2 (1999), pp. 17-24, ISSN 0962-9343  [abs]
  132. K Schulman, J Burke, M Drummond, L Davies, P Carlsson, J Gruger, A Harris, C Lucioni, R Gisbert, T Llana, E Tom, B Bloom, R Willke, H Glick, Resource costing for multinational neurologic clinical trials: methods and results., Health economics, vol. 7 no. 7 (November, 1998), pp. 629-38, ISSN 1057-9230  [abs]
  133. RJ Willke, HA Glick, D Polsky, K Schulman, Estimating country-specific cost-effectiveness from multinational clinical trials., Health economics, vol. 7 no. 6 (September, 1998), pp. 481-93, ISSN 1057-9230  [abs]
  134. KA Schulman, DB Mark, RM Califf, Outcomes and costs within a disease management program for advanced congestive heart failure., American heart journal, vol. 135 no. 6 Pt 2 Su (June, 1998), pp. S285-92, ISSN 0002-8703
  135. DP Sulmasy, BP Linas, KF Gold, KA Schulman, Physician resource use and willingness to participate in assisted suicide., Archives of internal medicine, vol. 158 no. 9 (May, 1998), pp. 974-8, ISSN 0003-9926  [abs]
  136. KA Schulman, D Dorsainvil, KR Yabroff, J DiCesare, J Felser, JM Eisenberg, HA Glick, Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. IL-3 BMT Study Team., Bone marrow transplantation, vol. 21 no. 6 (March, 1998), pp. 607-14, ISSN 0268-3369 [doi]  [abs]
  137. HA Glick, D Polsky, RJ Willke, WM Alves, N Kassell, K Schulman, Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States., Stroke; a journal of cerebral circulation, vol. 29 no. 2 (February, 1998), pp. 351-8, ISSN 0039-2499  [abs]
  138. DJ Gaskin, J Kong, NJ Meropol, KR Yabroff, C Weaver, KA Schulman, Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model., Medical decision making : an international journal of the Society for Medical Decision Making, vol. 18 no. 1 (March, 1998), pp. 84-94, ISSN 0272-989X  [abs]
  139. H Glick, R Willke, D Polsky, T Llana, WM Alves, N Kassell, K Schulman, Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage. Economic evaluation of a phase III clinical trial in Europe and Australia., International journal of technology assessment in health care, vol. 14 no. 1 (1998), pp. 145-60, ISSN 0266-4623  [abs]
  140. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook. J Natl Cancer Inst Monogr. 1998;(24):1-28.
  141. SS Rathore, SS Mehta, WL Boyko Jr, KA Schulman, Prescription medication use in older Americans: a national report card on prescribing., Family medicine, vol. 30 no. 10 (February, 1999), pp. 733-9, ISSN 0742-3225  [abs]
  142. KA Schulman, WL Boyko Jr, Evaluating cancer costs in NCI trials., Cancer treatment and research, vol. 97 (1998), pp. 37-52, ISSN 0927-3042  [abs]
  143. ZC Roulidis, HK DeChant, KA Schulman, Resource utilization control processes as indicators of quality in managed care organizations: a proposal., The American journal of medicine, vol. 103 no. 2 (August, 1997), pp. 146-51, ISSN 0002-9343  [abs]
  144. JM Mitchell, KR Meehan, J Kong, KA Schulman, Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 15 no. 7 (July, 1997), pp. 2644-51, ISSN 0732-183X  [abs]
  145. KA Schulman, LE Rubenstein, DM Seils, M Harris, J Hadley, JJ Escarce, Quality assessment in contracting for tertiary care services by HMOs: a case study of three markets., The Joint Commission journal on quality improvement, vol. 23 no. 2 (February, 1997), pp. 117-27, ISSN 1070-3241  [abs]
  146. E Tom, KA Schulman, Mathematical models in decision analysis., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, vol. 18 no. 1 (January, 1997), pp. 65-73, ISSN 0899-823X  [abs]
  147. D Polsky, HA Glick, R Willke, K Schulman, Confidence intervals for cost-effectiveness ratios: a comparison of four methods., Health economics, vol. 6 no. 3 (September, 1997), pp. 243-52, ISSN 1057-9230  [abs]
  148. KA Schulman, BP Linas, Pharmacoeconomics: state of the art in 1997., Annual review of public health, vol. 18 (1997), pp. 529-48, ISSN 0163-7525 [doi]  [abs]
  149. KA Schulman, T Llana, KR Yabroff, Economic assessment within the clinical development program., Medical care, vol. 34 no. 12 Suppl (December, 1996), pp. DS89-95, ISSN 0025-7079
  150. BC Knollmann, AP Corson, HL Twigg, KA Schulman, Assessment of joint review of radiologic studies by a primary care physician and a radiologist., Journal of general internal medicine, vol. 11 no. 10 (October, 1996), pp. 608-12, ISSN 0884-8734  [abs]
  151. JA Hirsch, CP Langlotz, J Lee, CP Tanio, RI Grossman, KA Schulman, Clinical assessment of MR of the brain in nonsurgical inpatients., AJNR. American journal of neuroradiology, vol. 17 no. 7 (August, 1996), pp. 1245-53, ISSN 0195-6108  [abs]
  152. KA Schulman, H Glick, M Buxton, M Sculpher, M Backhouse, L Bell, JM Eisenberg, The economic evaluation of the FIRST study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan International Randomized Survival Trial., Controlled clinical trials, vol. 17 no. 4 (August, 1996), pp. 304-15, ISSN 0197-2456  [abs]
  153. KA Schulman, Economics of bone marrow transplantation., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 14 no. 5 (May, 1996), pp. 1409-10, ISSN 0732-183X
  154. KA Schulman, LE Rubenstein, DR Abernethy, DM Seils, DP Sulmasy, The effect of pharmaceutical benefits managers: is it being evaluated?, Annals of internal medicine, vol. 124 no. 10 (May, 1996), pp. 906-13, ISSN 0003-4819  [abs]
  155. HK DeChant, WG Tohme, SK Mun, WS Hayes, KA Schulman, Health systems evaluation of telemedicine: a staged approach., Telemedicine journal : the official journal of the American Telemedicine Association, vol. 2 no. 4 (1996), pp. 303-12, ISSN 1078-3024  [abs]
  156. KA Schulman, M Buxton, H Glick, M Sculpher, G Guzman, J Kong, M Backhouse, J Mauskopf, L Bell, JM Eisenberg, Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial., International journal of technology assessment in health care, vol. 12 no. 4 (1996), pp. 698-713, ISSN 0266-4623  [abs]
  157. KR Yabroff, BP Linas, K Schulman, Evaluation of quality of life for diverse patient populations., Breast cancer research and treatment, vol. 40 no. 1 (1996), pp. 87-104, ISSN 0167-6806  [abs]
  158. KA Schulman, KR Yabroff, Measuring the cost-effectiveness of cancer care., Oncology (Williston Park, N.Y.), vol. 9 no. 6 (June, 1995), pp. 523-30, 533; discussion 533-8, ISSN 0890-9091  [abs]
  159. KA Schulman, LE Rubenstein, FD Chesley, JM Eisenberg, The roles of race and socioeconomic factors in health services research., Health services research, vol. 30 no. 1 Pt 2 (April, 1995), pp. 179-95, ISSN 0017-9124  [abs]
  160. KA Schulman, LE Rubenstein, HA Glick, JM Eisenberg, Relationships between sponsors and investigators in pharmacoeconomic and clinical research., PharmacoEconomics, vol. 7 no. 3 (March, 1995), pp. 206-20, ISSN 1170-7690  [abs]
  161. K Schulman, Cost-effectiveness analyses., The New England journal of medicine, vol. 332 no. 2 (January, 1995), pp. 124; author reply 124-5, ISSN 0028-4793
  162. JH Lee, HA Glick, B Kinosian, KA Schulman, An interactive computer system for formulary management using cost-effectiveness analysis., M.D. computing : computers in medical practice, vol. 12 no. 1 (March, 1995), pp. 59-65, ISSN 0724-6811
  163. KA Schulman, HA Glick, Economic evaluation of high-dose chemotherapy and bone marrow transplantation for patients with breast cancer of stage II or IIIA with more than 10 positive lymph nodes at surgical excision., Journal of the National Cancer Institute. Monographs no. 19 (1995), pp. 45-50, ISSN 1052-6773  [abs]
  164. KA Schulman, HA Glick, KR Yabroff, JM Eisenberg, Introduction to clinical economics: assessment of cancer therapies., Journal of the National Cancer Institute. Monographs no. 19 (1995), pp. 1-9, ISSN 1052-6773  [abs]
  165. ZC Roulidis, KA Schulman, Physician communication in managed care organizations: opinions of primary care physicians., The Journal of family practice, vol. 39 no. 5 (November, 1994), pp. 446-51, ISSN 0094-3509  [abs]
  166. NA Solomon, HA Glick, CJ Russo, J Lee, KA Schulman, Patient preferences for stroke outcomes., Stroke; a journal of cerebral circulation, vol. 25 no. 9 (September, 1994), pp. 1721-5, ISSN 0039-2499  [abs]
  167. K Schulman, DP Sulmasy, D Roney, Ethics, economics, and the publication policies of major medical journals., JAMA : the journal of the American Medical Association, vol. 272 no. 2 (July, 1994), pp. 154-6, ISSN 0098-7484  [abs]
  168. KA Schulman, RC McDonald, LA Lynn, I Frank, NA Christakis, JS Schwartz, Screening surgeons for HIV infection: assessment of a potential public health program., Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, vol. 15 no. 3 (March, 1994), pp. 147-55, ISSN 0899-823X  [abs]
  169. KA Schulman, JJ Escarce, JM Eisenberg, JC Hershey, MJ Young, DM McCarthy, SV Williams, Assessing physicians' estimates of the probability of coronary artery disease: the influence of patient characteristics., Medical decision making : an international journal of the Society for Medical Decision Making, vol. 12 no. 2 (June, 1992), pp. 109-14, ISSN 0272-989X  [abs]
  170. KA Schulman, HA Glick, H Rubin, JM Eisenberg, Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent., JAMA : the journal of the American Medical Association, vol. 266 no. 24 (December, 1991), pp. 3466-71, ISSN 0098-7484  [abs]
  171. KA Schulman, LA Lynn, HA Glick, JM Eisenberg, Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection., Annals of internal medicine, vol. 114 no. 9 (May, 1991), pp. 798-802, ISSN 0003-4819  [abs]
  172. KA Schulman, B Kinosian, TA Jacobson, H Glick, MK Willian, H Koffer, JM Eisenberg, Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management., JAMA : the journal of the American Medical Association, vol. 264 no. 23 (December, 1990), pp. 3025-33, ISSN 0098-7484  [abs]
  173. K Schulman, Screening for colorectal cancer., Annals of internal medicine, vol. 113 no. 4 (August, 1990), pp. 333-4, ISSN 0003-4819


©2013 Duke Global Health Institute | Contact Us | Employment | Make a Gift | Duke University | Duke Medicine | Interdisciplinary Studies